Mount Sinai Physicians First in United States to Perform Cardiac Catheter Ablation Procedure Using Innovative Device
Mount Sinai physicians have become the first in the country to perform cardiac ablation procedures using a new, state-of-the-art catheter. Vivek Reddy, MD, The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology and his colleagues, Srinivas Dukkipati, MD, Director of the Electrophysiology Laboratory at The Mount Sinai Hospital, and Subbarao Choudry, MD, Assistant Clinical Professor, Cardiology, performed the first and second procedures in the United States with the IntellaNav OI catheter on September 29 and 30.
The IntellaNav OI, made by Boston Scientific, has both internal and external tip cooling during ablation, now enhanced with IntellaNav magnetic tracking technology for increased accuracy, efficiency and performance during catheter ablation procedures. Both patients had atypical atrial flutter rhythms that were successfully eliminated with the ablation procedures. Atrial flutter is an abnormal heart rhythm that occurs in the atria of the heart.
The newly FDA-approved IntellaNav OI catheter features magnetic sensors that track the location of the catheter while delivering radio-frequency energy into the heart muscle, creating heat to destroy a small area of the tissue responsible for the abnormal heart rhythm. The IntellaNav OI catheter provides cooling of the catheter tip to help prevent char and coagulum formation for additional safety and more effective treatment of the arrhythmia within ablation procedures.
"We are committed to offering the latest technologies to treat our patients, and are pleased to be one of the first institutions in the United States to offer the innovative IntellaNav OI,” said Dr. Reddy. “The catheter provides additional safety within ablation procedures and is an important addition to our full suite of services to diagnose and treat a variety of heart rhythm conditions.”
Mount Sinai is a pioneer in the diagnosis and treatment of patients with abnormal heart rhythms. Its electrophysiology department has been leading the development of new arrhythmia technologies since 1909, when one of its physicians became the first in the United States to use an electrocardiogram. Today, the Helmsley Center for Electrophysiology at Mount Sinai, directed by Dr. Reddy, provides the full spectrum of therapies, from procedures that implant devices for regulating heart rhythms (such as pacemakers) to procedures that use catheters for fixing the source of the abnormal heartbeat (called ablations).
In an effort to make ablations safer and more effective, the Center has been the first in the country to use several breakthrough technologies, including a visually guided laser balloon catheter in 2009 and the TactiCath force-sensing catheter in 2011, as well as a new generation of visually guided catheters in 2012. Dr. Reddy was the first physician in the world to use several new ablation techniques to treat atrial fibrillation, such as the cryoballoon catheter and robotic navigation. In addition, in 2014, Dr. Reddy implanted inside a patient's heart the first, innovative, miniature leadless pacemaker in the United States at The Mount Sinai Hospital.
Dr. Reddy is a consultant to Boston Scientific, the manufacturer of the IntellaNav OI.
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest integrated delivery system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The Health System includes approximately 7,480 primary and specialty care physicians; 11 joint-venture ambulatory surgery centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools", aligned with a U.S. News & World Report's "Honor Roll" Hospital, No. 12 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of top U.S. hospitals; it is one of the nation's top 20 hospitals in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Geriatrics, Gynecology, Nephrology, Neurology/Neurosurgery, and Orthopedics in the 2019-2020 "Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 12th nationally for Ophthalmology and the South Nassau Communities Hospital is ranked 35th nationally for Urology. Mount Sinai Beth Israel, Mount Sinai St. Luke's, Mount Sinai West, and South Nassau Communities Hospital are ranked regionally.